Clinical trials: STENTS
In-stent Restenosis After Carotid Artery Stenting
Carotid Artery Stenting With Cilostazol Addition for Restenosis
CAS-CARE study was conducted to evaluate the inhibitory effect of cilostazol, compared to that of other antiplatelet drugs, on in-stent restenosis following carotid artery stenting (CAS) in patients scheduled to undergo CAS.
- Trial name
- CAS-CARE (NCT01261234)
- Testing
- Cilostazol or Non-Cilostazol
- Where
- Japan
- Volunteers
- 707 people
- Sponsor
- Kobe City General Hospital
Biliary Tract, Biliary Tract Diseases
Biodegradable Stent Implantation in Biliary Benign Strictures.
Spanish registry of resorbable stent implantation in biliary benign strictures. This registry is sponsored by the Spanish Society of Vascular and Interventional Radiology (SERVEI) and conducted by the Research Group GITMI (Group…
- Conditions
- Biliary Tract, Biliary Tract Diseases, Stenosis, Follow-Up Studies
- Trial name
- BiELLA (NCT04115696)
- Testing
- Percutaneous placement of biodegradable biliary stents
- Where
- 2 sites in Spain
- Volunteers
- 150 people
- Sponsor
- Group of Research in Minimally Invasive Techniques
Stent Occlusion, Long-term Oncologic Results
Long-term Outcomes of Colonic Stent as a "Bridge to Surgery" for Malignant Large-bowel Obstruction
Study of long-term outcomes of colonic stent as a "bridge to surgery" for malignant large-bowel obstruction.
- Trial name
- NCT04111042
- Testing
- stenting
- Where
- Spain
- Volunteers
- 117 people
- Sponsor
- Corporacion Parc Tauli
In-stent Restenosis, Ischemic Heart Disease
The PREVAIL Study
To evaluate the clinical safety and efficacy of a new Medtronic Coronary Drug-Coated Balloon Catheter in the treatment of de novo lesions, small vessel disease or In-Stent Restenosis with coronary lesions previously treated with…
- Conditions
- In-stent Restenosis, Ischemic Heart Disease, Coronary Artery Disease
- Trial name
- PREVAIL (NCT03260517)
- Testing
- Medtronic Coronary Drug-Coated Balloon Catheter
- Where
- 10 sites in Belgium, Italy and 1 more
- Volunteers
- 50 people
- Sponsor
- Medtronic Vascular
Stent Thrombosis
Factors Contribute to Very Late Stent Thrombosis After New Generation DES Implantation in China
The investigators sought to identify and verify the potential correlates and mechanisms of Very Late Stent Thrombosis (VLST) after the implantation of new generation drug eluting steng in China from an analysis of multicenter…
- Trial name
- NCT03491891
- Where
- China
- Volunteers
- 8,476 people
- Sponsor
- The First Hospital of Jilin University
Stent Thrombosis
Register of Patients Benefiting From a Coronary Bifurcation Angioplasty at the University Hospital of Nîmes and Montpellier in 2017
Cardiovascular diseases are the second leading cause of death in France and the world's leading cause.Coronary bifurcations are conducive to the development of atheromatous lesions due to flow turbulence generating a…
- Trial name
- Register (NCT04011046)
- Testing
- Stent
- Where
- France
- Volunteers
- 143 people
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
Coronary Artery Disease, Drug-eluting Stent
Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention
Clinical trial with an "European Community marked" medical device in patients with ischemic heart disease and clinical indication of coronary revascularization with drug-eluting stent.
- Trial name
- NCT03049657
- Testing
- Angiolite, Xience
- Where
- 11 sites in Spain
- Volunteers
- 220 people
- Sponsor
- Cardiva2 S.L.
Coronary Artery Disease, In-stent Restenosis
The Effect of Sleep Quality on Coronary Artery Disease and In Stent Restenosis
This is a cross-sectional and follow-up study. We analysis the relationship of sleep quality on coronary artery disease(CAD) and in stent restenosis(ISR).
- Trial name
- NCT03874481
- Testing
- Observation
- Where
- China
- Volunteers
- 958 people, healthy volunteers welcome
- Sponsor
- China National Center for Cardiovascular Diseases
Double J Stent
Incidence and Factors Associated With Double-J Urinary Stent Infection (IJJ)
The aim of the study was to determine the incidence and factors associated with double-J urinary stent infection.
- Trial name
- IJJ (NCT03869580)
- Where
- France
- Volunteers
- 800 people
- Sponsor
- Centre Hospitalier Universitaire de Besancon
Angioplasty, Chronic Coronary Occlusion
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study
This is a prospective, observational, single-arm, open-label, multicenter, postapproval registry study in China. The purpose of this study is to: Evaluate the continued safety and effectiveness of the XIENCE V EECSS in a cohort…
- Conditions
- Angioplasty, Chronic Coronary Occlusion, Stent Thrombosis, Vascular Disease
- Trial name
- XV CHINA SAS (NCT01249027)
- Testing
- XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)
- Where
- United States
- Volunteers
- 2,605 people
- Sponsor
- Abbott Medical Devices
Longterm Indwelling Ureteral Stent
Assessment of Longterm Ureteral Stenting
This study is performed to analyze various aspects of biofilms on ureteral stents in a longterm setting.
- Trial name
- NCT02871609
- Testing
- Stent examination, urinary analysis, USSQ questionnaire
- Where
- Switzerland
- Volunteers
- 91 people
- Sponsor
- Cantonal Hospital of St. Gallen
CHD - Coronary Heart Disease, Percutaneous Coronary Intervention
Optical Coherence Tomography Guided Percutaneous Coronary Intervention for Drug-eluting In-stent Restenosis
This study is a prospective, registry trial aimed to compare the clinical and angiographic outcomes of OCT-guided and angiography-guided PCI in patients with coronary DES-ISR.
- Conditions
- CHD - Coronary Heart Disease, Percutaneous Coronary Intervention, In-stent Restenosis
- Trial name
- NCT03809754
- Testing
- Percutaneous Coronary Intervention under OCT, Percutaneous Coronary Intervention under Angiography
- Where
- China
- Volunteers
- 240 people
- Sponsor
- Chinese PLA General Hospital
Unstable Angina Pectoris, Coronary Stent Implantation
Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation
The study is to evaluate efficacy and safety of low dose of ticagrelor therapy for Chinese unstable angina patients treated with non-urgent coronary stent implantation, to examine whether lower dose ticagrelor (45 mg twice-daily)…
- Trial name
- NCT03620760
- Testing
- Ticagrelor 90 mg, Ticagrelor 45 mg, Aspirin
- Where
- China
- Volunteers
- 2,036 people
- Sponsor
- Xiaofan Wu
Aortic Stent Graft
Blood Pressure Changes During Moderate Intensity Strength Training in Aortic Stent-graft Patients
Patients with an aortic stent graft are recommended to do muscle strengthening exercise as part of their rehabilitation. But, as excess blood pressure pose a risk to the integrity of the stent graft, high intensity muscle…
- Trial name
- NCT03424863
- Testing
- Moderate Intensity Muscle Strengthening
- Where
- Denmark
- Volunteers
- 46 people, healthy volunteers welcome
- Sponsor
- Marius Henriksen
Ruptured Intracranial Aneurysms, Unruptured Intracranial Aneurysms
Treatment of Ruptured Intracranial Aneurysms in China.
Ruptured intracranial aneurysms is currently a common disease that seriously affects human health and quality of life due to its high morbidity,high mortality and high disability.
- Conditions
- Ruptured Intracranial Aneurysms, Unruptured Intracranial Aneurysms, Stent-Assisted Coiling, Non-Stent-Assisted Coiling
- Trial name
- NCT03462433
- Where
- China
- Volunteers
- 1,384 people
- Sponsor
- Zhujiang Hospital
Lower Urinary Tract Discomfort, Stent Pain
Randomization of Botox for Stent Pain and Irritative Voiding Symptoms
Botulinum toxin type A (Botox A) has shown great success in treating certain urologic conditions. A recent study has documented that Botox injected around the ureteral orifice (or place where the tube that connects the kidney to…
- Trial name
- NCT02078895
- Testing
- Botox
- Where
- United States
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- University of California, Irvine
Coronary Disease, Drug Eluting Stent
Outcome of CHAllenging lesioNs and Patients Treated With Polymer Free Drug-CoatEd Stent
Length of DAT (Dual Antiplatelet therapy) represents one of the most challenging choices for interventional cardiologist. Prolonged DAT reduces risk of subsequent MI (Myocardial Infarction) with an increase in major bleedings…
- Conditions
- Coronary Disease, Drug Eluting Stent, STEMI
- Trial name
- CHANCE (NCT03622203)
- Testing
- Biofreedom
- Volunteers
- 1,000 people
- Sponsor
- A.O.U. Città della Salute e della Scienza
Metal Allergy, Contact Allergy
Metal Allergy In-Stent Restenosis Study
In-stent restenosis remains one of the most challenging problems in patients after coronary artery angioplasty. Angiographically, it is discovered in 10% of the patients after drug-eluting stent (DES) implantation.
- Conditions
- Metal Allergy, Contact Allergy, Restenoses, Coronary, In-stent Restenosis
- Trial name
- RESTALL (NCT03588962)
- Testing
- In-stent restenosis
- Volunteers
- 1,000 people
- Sponsor
- Silesian Centre for Heart Diseases
Coronary In-stent Restenosis
Retrospective Long-term Safety and Efficacy Study of the Beta-Cath(TM) 3.5F System
The study will evaluate the long-term safety and efficacy of intravascular beta radiation therapy to treat coronary in-stent restenosis using the Beta-Cath(TM) 3.5F System; data will be collected retrospectively on patients…
- Trial name
- NCT00852176
- Where
- United States
- Volunteers
- 200 people
- Sponsor
- Best Vascular, Inc.
Stent Complications
Combined Use of a Medical Device and a Dietary Complement in Patient Urinary pH Control in Patients With an Implanted Double J Stent.
This study evaluates the effectivity in urinary pH Control and the prevention of calcification in Double J stent using a device combined with the intake of dietary supplements.
- Trial name
- NCT03343275
- Testing
- Lit control pHDown
- Where
- 9 sites in Spain
- Volunteers
- 105 people
- Sponsor
- Devicare S.L.